GlassScriptPhysician profile
Andres M Reyes
NPI 1205829074
$1,073.42
in general payments reported to CMS, 2019-2025
16 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2021: $20.80 · 2022: $25.70 · 2023: $344 · 2024: $109 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.07 |
| Education | $139.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $195.09 | 2024-2025 | Krystexxa |
| Pfizer INC. | $125.00 | 2019 | |
| Abiomed | $124.89 | 2019 | |
| Insmed, INC. | $122.83 | 2019 | |
| Nxstage Medical, INC. | $119.92 | 2023 | Liberty Select Cycler, Nxstage System One |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Shield Therapeutics INC | $67.93 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $54.77 | 2022-2023 | Jynarque |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.82 | 2025 | Xifaxan |
| Calliditas Therapeutics US INC. | $22.27 | 2023 | Tarpeyo |
| Boston Scientific Corporation | $21.88 | 2025 | Watchman Flx |
| Medtronic, INC. | $20.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Opko Pharmaceuticals, LLC | $19.52 | 2023 | Rayaldee |
| Fresenius USA Marketing, INC. | $18.70 | 2023 | Korsuva, Velphoro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.39 | 2023 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.